Home
Conditions
Adult Acute Promyelocytic Leukemia (M3)

Clinical trial condition

Adult Acute Promyelocytic Leukemia (M3)

Explore clinical trials studying Adult Acute Promyelocytic Leukemia (M3). Study availability and eligibility vary by location and protocol.

15 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Adult Acute Promyelocytic Leukemia (M3) trial results

Completed

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

NCT01588015

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia

NCT01031368

Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +31 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT00602225

Conditions: Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +15 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT00062075

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +15 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

Vanderbilt University Nashville, Tennessee, United States

View Trial Details

Completed

Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia

NCT00588809

Conditions: Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Promyelocytic Leukemia (M3), Bone Marrow Diseases, +13 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia

NCT01146223

Conditions: Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Promyelocytic Leukemia (M3), +9 more
Locations: Children's Oncology Group Monrovia, California, United States

View Trial Details

Completed

Vorinostat in Treating Patients With Acute Myeloid Leukemia

NCT00305773

Conditions: Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +31 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes

NCT00301938

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +56 more
Locations: University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes

NCT00331513

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +39 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia

NCT00003934

Conditions: Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Promyelocytic Leukemia (M3), Childhood Acute Promyelocytic Leukemia (M3), +10 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Adult Acute Promyelocytic Leukemia (M3)

Adult Acute Promyelocytic Leukemia (M3) trial results

Related conditions